DCGI orders recall of 45 medications for quality issues, with 5 identified as spurious.

India's drug regulator, the DCGI, has ordered the recall of 45 medications for failing quality standards. Reports of 50 banned "fake" medicines were clarified as incorrect; only five were identified as spurious. The CDSCO tests around 2,000 samples monthly, with 40-50 failing various parameters. The regulator is taking action against the makers of the spurious drugs and continues to work on improving compliance under the Drug and Cosmetics Act.